Kate Hacker
About Kate Hacker
Kate Hacker is the Senior Director of Strategy & Planning Analytics at Bristol Myers Squibb, with over 20 years of experience in financial analysis, strategic planning, and portfolio management within the biopharma industry.
Title
Kate Hacker currently holds the position of Senior Director, Strategy & Planning Analytics at Bristol Myers Squibb. In this role, she leads the strategic planning and analytics efforts for multiple high-impact projects within the company.
Work Experience at Bristol Myers Squibb
Kate Hacker has an extensive history with Bristol Myers Squibb, where she has held significant roles over the years. She started as an Analyst, R&D Resource Planning and Management from 2003 to 2004. She then progressed to Manager, Product Portfolio & Asset Strategy from 2010 to 2011, followed by Associate Director, Product Portfolio & Asset Strategy from 2011 to 2015. She also served as Director, Financial Analysis Mergers & Acquisitions from 2015 to 2020, before her current role since 2020.
Previous Professional Experience
Before her tenure at Bristol Myers Squibb, Kate Hacker accumulated diverse experience in the pharmaceutical and finance sectors. She was a Commercial Leadership Development Program Associate at Johnson & Johnson from 2006 to 2009 and interned as a Product Management Intern at AbbVie in 2005. Additionally, she held the role of Sr Financial Analyst at Weber Shandwick Worldwide/Interpublic Group of Companies from 2000 to 2002 and began her career as an Analyst at Bowles Hollowell Conner/First Union Securities, Inc. from 1998 to 2000.
Education and Certifications
Kate Hacker pursued her higher education at some of the most prestigious institutions. She earned an AB in Economics from Harvard University and an MBA with a focus on Marketing, Finance, and Strategic Management from The University of Chicago Booth School of Business. She further attained a Professional Certificate in Strategic Decision and Risk Management from Stanford University. She also attended The Lawrenceville School.
Industry Expertise and Contributions
Kate Hacker has over 20 years of experience in financial analysis, strategic planning, and portfolio management within the biopharma industry. She has played a key role in the successful integration of multiple mergers and acquisitions at Bristol Myers Squibb and developed portfolio optimization strategies that improved asset management efficiency. Known for her collaborative approach, she regularly works with cross-functional teams to drive strategic initiatives and support corporate growth. She also mentors and develops future leaders within the organization.